Page 166 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 16 ฉบับที่ 1

156

§«“¡ª≈Õ¥¿—¬¢Õß “√ °—¥¢¡‘Èπ™—𷧪´Ÿ≈ °—∫ ¬“
‡Õ° “√Õâ“ßÕ‘ß
μâ“πÕ—°‡ ∫‰Õ∫Ÿ‚ª√‡øπ∫àß™’È«à“ “√ °—¥¢¡‘Èπ™—π
1. Monographs of Selected Thai Materia Medica Volume
·§ª´Ÿ≈™à«¬„À⺟âªÉ«¬¡’Õ“°“√ª«¥¢âÕ §«“¡Ωó¥¢âÕ 1. 1st. Bangkok: Amarin Printing & Publishing Book
publishers company; 2009. p. 238-42.
·≈–‡æ‘Ë¡§«“¡ “¡“√∂„π°“√„™âß“π¢âÕ‰¥â‰¡àμà“ß®“°
2. Rege, NN, Thatte UM, and Dahanukar SA. Adaptogenic
°“√„™â¬“‰Õ∫Ÿ‚ª√‡øπ ∑’Ë ”§—≠ ¡’§«“¡ª≈Õ¥¿—¬¥’ properties of six rasayana herbs used in Ayurvedic
medicine. Phytother Res. 1999;13(4):275-91.
‚¥¬‡©æ“–º≈¢â“߇§’¬ß√–∫∫∑“߇¥‘πÕ“À“√ (Õ“°“√
3. DûSouza P, Amit A, Saxena VS, Bagchi D, Bagchi M,
ª«¥∑âÕß/∑âÕßÕ◊¥) ∑’Ë¡’πâÕ¬°«à“°“√„™â¬“μâ“πÕ—°‡ ∫ Stohs SJ. Antioxidant properties of Aller-7, a novel
polyherbal formulation for allergic rhinitis. Drugs Exp
‰Õ∫Ÿ‚ª√‡øπ ´÷Ëß∑’˺à“π¡“ à«π„À≠à∑“ß°“√·æ∑¬å-
Clin Res. 2004;30(3):99-109.
·ºπ‰∑¬¡—°„™â«‘∏’°“√√—°…“¥â«¬≈Ÿ°ª√–§∫ À“°¡’π” 4. Chainani-Wu N. Safety and Anti-Inflammatory Activity
of Curcumin: A Component of Tumeric (Curcuma longa).
“√®“°¢¡‘Èπ™—π¡“æ—≤π“„À⇪ìπ¬“√—∫ª√–∑“π∑’Ë
J Altern Complement Med. 2003;9(1):161-8.
–¥«°¡“°¢÷Èπ æ√âÕ¡°—∫¡’°“√ √â“ߧ«“¡√Ÿâ§«“¡
5. Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon
‡¢â“„®„π°≈‰°°“√√—°…“·≈–ª√– ‘∑∏‘º≈°“√„™â¬“ °Á F, Planchat E, Abrial C, et al. Phase I dose escalation
trial of docetaxel plus curcumin in patients with
®– àߺ≈„À⬓¢¡‘Èπ™—π¡’°“√ —Ëß®à“¬‡æ‘Ë¡ Ÿß¢÷Èπ ‚¥¬
advanced and metastatic breast cancer. Cancer Biol
§“¥«à“®–¢¬“¬μ—«„πÕ—μ√“√âÕ¬≈– 40 μàÕªï À√◊Õ¡’ Ther. 2010;9(1):8-14.
6. Srimal RC, Dhawan BN. Pharmacology of diferuloyl
®”π«π°“√ —Ëß®à“¬ª√–¡“≥ 100 ≈â“π§√—Èß/ªï
methane (curcumin), a non-steroidal anti- inflammatory
agent. J Pharm Pharmacol 1973;25(6):447-52.
∫∑ √ÿª 7. Therapeutic Research Center. Tumeric. [Internet]. 2017
Dec [cited 2017 Dec 10]; [10 screens]. Available from:
º≈≈—æ∏å∑’Ë®–‡°‘¥¢÷Èπ„π‡™‘ßª√‘¡“≥·≈–§ÿ≥¿“æ https://naturalmedicines.therapeuticresearch.com/
¢Õßπ‚¬∫“¬°“√ π—∫ πÿπ°“√„™â¬“ ¡ÿπ‰æ√®”π«π 3 8. Calabrese C, Berman SH, Babish JG, et al. A phase I
trial of andrographolide in HIV positive patients and
√“¬°“√ ‰¥â·°à ¬“øÑ“∑–≈“¬‚®√ ¬“¡–¢“¡ªÑÕ¡ ·≈–
normal volunteers. Phytother Res. 2000;14:333-8.
¬“¢¡‘Èπ™—π „π ∂“π∫√‘°“√ —ß°—¥°√–∑√«ß “∏“√≥ ÿ¢ 9. Therapeutic Research Center. Indian Gooseberry.
[Internet]. 2018 Feb [cited 2018 Feb 7]; [4 screens].
‡ªìπ°“√ π—∫ πÿπ„À⇰‘¥°“√„™â¬“ ¡ÿπ‰æ√Õ¬à“ß
Available from: https://naturalmedicines.therapeuticr
°«â“ߢ«“ß ∑”„Àâª√–™“™π‡¢â“∂÷ß√–∫∫∫√‘°“√ ÿ¢¿“æ esearch.com/
10. Health Canada Monograph. Monograph: Turmeric - Oral
∑’Ë πÕßμÕ∫π‚¬∫“¬¢Õß√—∞∫“≈·≈–°√–∑√«ß
- Health Canada. [Internet]. 2010 Oct [cited 2017 Dec
“∏“√≥ ÿ¢ μ≈Õ¥®π·ºπ¬ÿ∑∏»“ μ√å√–¥—∫™“μ‘ 10]; [5 screens]. Available from: http://webprod.hc-
sc.gc.ca/nhpid-bdipsn/monoReq.do?id=216&lang=eng
¥â“π ÿ¢¿“æ·≈– ¡ÿπ‰æ√ ∂“π∫√‘°“√¿“§√—∞¡’°“√
11. National Drug System Development Committeeûs
„™â¬“Õ¬à“ß ¡‡Àμÿ ¡º≈ (RDU) ‚¥¬„™â¬“ ¡ÿπ‰æ√
notification on national list of essential medicines B.E.
∑¥·∑π¬“π”‡¢â“®“°μà“ߪ√–‡∑» Õ—π‡ªìπ°“√‡æ‘Ë¡ 2556 (2013). Government gazette, Vol. 130, Special part
126d, dated 30 Sept 2013. p. 195.
√“¬‰¥â„Àâ·°àª√–‡∑» √«¡∂÷߇ªìπ°“√°√–®“¬√“¬‰¥â
12. Therapeutics Goods Administration, Department of
‰ª¬—߇°…μ√°√ºŸâ‡æ“–ª≈Ÿ°«—μ∂ÿ¥‘∫ ¡ÿπ‰æ√ ‡ªìπ°“√ Health, Australian Government. Safety review of
Andrographis paniculata and anaphylactic /allergic
™à«¬ π—∫ πÿπ„À⇰‘¥°“√æ—≤π“ ¡ÿπ‰æ√‰¥âÕ¬à“ß
reactions. [Internet]. 2015 Oct [cited 2017 Dec 20];
§√∫«ß®√ μ—Èß·μàμâπ∑“ß °≈“ß∑“ß ·≈–ª≈“¬∑“ß Version 1.0: [29 screens]. Available from: https://